![Ca-125 in Ovarian Cancer: To Test or Not to Test? – Latest and Best Treatments in Oncology & Radiotherapy Ca-125 in Ovarian Cancer: To Test or Not to Test? – Latest and Best Treatments in Oncology & Radiotherapy](https://drbhnglatest.files.wordpress.com/2017/09/screen-shot-2018-06-11-at-10-05-53-pm.png?w=1108)
Ca-125 in Ovarian Cancer: To Test or Not to Test? – Latest and Best Treatments in Oncology & Radiotherapy
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig1_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer - ScienceDirect Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825813010147-t1.jpg)
Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer - ScienceDirect
![Test Tube with blood sample for CA 125 test. Tumor Marker for ovarian cancer. A medical testing concept in the laboratory background. Stock Photo | Adobe Stock Test Tube with blood sample for CA 125 test. Tumor Marker for ovarian cancer. A medical testing concept in the laboratory background. Stock Photo | Adobe Stock](https://t3.ftcdn.net/jpg/04/42/73/32/360_F_442733215_UnLqlOzmMAMA1RZZN3AjtbVRy1dBrUDs.jpg)
Test Tube with blood sample for CA 125 test. Tumor Marker for ovarian cancer. A medical testing concept in the laboratory background. Stock Photo | Adobe Stock
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure1.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Table 1 from Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. | Semantic Scholar Table 1 from Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5d6f060039736a337655ff8c37f0605527be3327/2-Table1-1.png)
Table 1 from Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. | Semantic Scholar
![Raised CA125 – what we actually know… - Howe - 2021 - The Obstetrician & Gynaecologist - Wiley Online Library Raised CA125 – what we actually know… - Howe - 2021 - The Obstetrician & Gynaecologist - Wiley Online Library](https://obgyn.onlinelibrary.wiley.com/cms/asset/7d7a4bac-4449-4be0-82ed-9187e01a5506/tog12704-fig-0002-m.jpg)
Raised CA125 – what we actually know… - Howe - 2021 - The Obstetrician & Gynaecologist - Wiley Online Library
The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study | PLOS Medicine
![CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice](https://bjgp.org/content/bjgp/71/707/e465/F1.large.jpg?width=800&height=600&carousel=1)
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice
![A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1983/nejm_1983.309.issue-15/nejm198310133091503/20130822/images/img_medium/nejm198310133091503_t1.jpeg)
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)